Article Per Year (5 Year)
p-Index From 2021 - 2026
0.408
P-Index
This Author published in this journals
All Journal Surabaya Biomedical Journal
maya rafida, maya rafida
Unknown Affiliation
Dentistry Health Professions Medicine & Pharmacology Nursing

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
HUBUNGAN USIA, INDEKS MASA TUBUH, DAN GRAVIDA PADA IBU HAMIL DENGAN PREEKLAMPSIA DI RUMAH SAKIT MUHAMMADIYAH SURABAYA: RELATIONSHIP OF AGE, BODY INDEX, AND GRAVIDA IN PREGNANT WOMEN AND PREECLAMPSIA IN MUHAMMADIYAH HOSPITAL SURABAYA maya rafida, maya rafida
Surabaya Biomedical Journal Vol. 1 No. 3 (2022): Mei
Publisher : Fakultas Kedokteran, Universitas Hang Tuah

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30649/sbj.v1i3.25

Abstract

Preeclampsia is one of the causes of increased maternal mortality and morbidity, based on the Republic of Indonesia Ministry of Health data in 2016, the maternal mortality rate in East Java Province reached 91.00 per 100,000 live births. The highest cause of maternal death in 2016 was preeclampsia / eclampsia, which was 30.90% or as many as 165 people. Preeclampsia can appear at more than 20 weeks' gestation marked by hypertension and accompanied by proteinuria. This study aims to determine the relationship of age, body mass index, and gravida to pregnant women who have preeclampsia at Muhammadiyah Hospital in Surabaya. This type of research uses a cross sectional study, sample selection using total sampling with a minimum sample of 70 samples. Large samples obtained 210 respondents, as many as 105 experienced preeclampsia and 105 respondents did not experience preeclampsia. Based on the results of bivariate statistical tests found age is a risk factor for the incidence of preeclampsia (p: 0.039 <0.05), body mass index is associated with the incidence of preeclampsia (p: 0.002 <0.05) and gravida has no relationship with the incidence of preeclampsia (p: 0.410 > 0.05). Based on the multivariate test, there was an influence of age 36-45 years on the incidence of preeclampsia with a risk of 4.060 times experiencing preeclampsia compared to the age of 20-35 years, obese affected the incidence of preeclampsia with a risk of 4.696 times experiencing preeclampsia compared to normalweight and gravida influencing the incidence of preeclampsia with a risk of 2,099 times experiencing preeclampsia. The conclusion of this research is that there is a relationship between age, body mass index and gravida in preeclampsia at Muhammadiyah Hospital in Surabaya.
KLIMAKTERIUM: KLIMACTERIUM maya rafida, maya rafida
Surabaya Biomedical Journal Vol. 1 No. 3 (2022): Mei
Publisher : Fakultas Kedokteran, Universitas Hang Tuah

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30649/sbj.v1i3.26

Abstract

Background: Menopause is a condition in which women experience physiological failure of ovarian function, as a result of the loss of activity of the ovarian follicles. Menopause is the stage when a woman's menstrual bleeding stops. At the age of 50 years, women enter menopause so that there is a decrease or loss of the hormone estrogen which causes women to experience complaints or disorders that often interfere with daily activities and can even reduce their quality of life. Objectives: to determine risk factors, pathophysiology, clinical manifestations, diagnosis and management of climacteric. Methods: collecting and analyzing journals using pubmed search media, google scholar, NCBI, ScienceDirect with keywords Conclusion: The climacteric phase consists of premenopause, perimenopause, menopause and postmenopause phases. The premenopause phase is the period for 4-5 years before the onset of menopause. This phase begins when a woman is 40 years old, characterized by irregular, prolonged menstrual cycles, little or a lot of menstrual blood, and sometimes accompanied by pain. The perimenopause phase is a transitional phase between pre-menopausal and postmenopausal. This phase is characterized by irregular menstrual cycles and levels of Follicle Stimulating Hormone (FSH), luteinizing hormone (LH), and highly variable estrogen (normal, high, or low). The menopausal phase is the condition of women who have no longer menstruating calculated after 12 months from the last menstruation, which is characterized by blood FSH levels >35 mIU/ml and estradiol levels <30 pg/ml.
Co-Authors